(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 19.63%502.15M | -6.63%898.73M | -16.52%419.76M | -6.62%962.57M | -2.97%502.86M | 29.87%1.03B | 53.21%518.27M | -2.27%793.73M | -16.23%338.29M | -13.92%812.18M |
Operating income | 19.63%502.15M | -6.63%898.73M | -16.52%419.76M | -6.62%962.57M | -2.97%502.86M | 29.87%1.03B | 53.21%518.27M | -2.27%793.73M | -16.23%338.29M | -13.92%812.18M |
Cost of sales | -12.81%-364.76M | 1.81%-675.91M | 11.92%-323.34M | 9.90%-688.38M | 5.53%-367.1M | -24.99%-764M | -44.86%-388.6M | 3.17%-611.26M | 15.40%-268.26M | 3.28%-631.25M |
Operating expenses | -12.81%-364.76M | 1.81%-675.91M | 11.92%-323.34M | 9.90%-688.38M | 5.53%-367.1M | -24.99%-764M | -44.86%-388.6M | 3.17%-611.26M | 15.40%-268.26M | 3.28%-631.25M |
Gross profit | 42.50%137.39M | -18.73%222.82M | -28.98%96.42M | 2.76%274.19M | 4.69%135.76M | 46.23%266.81M | 85.17%129.68M | 0.85%182.47M | -19.27%70.03M | -37.78%180.93M |
Selling expenses | -45.20%-17.34M | -10.58%-28.95M | 0.57%-11.95M | -2.19%-26.18M | -9.97%-12.01M | -32.16%-25.62M | -12.32%-10.93M | -21.46%-19.38M | -36.52%-9.73M | 39.86%-15.96M |
Administrative expenses | -10.12%-85.67M | 18.77%-149.37M | 17.94%-77.8M | -25.11%-183.87M | -17.77%-94.8M | -25.94%-146.97M | -20.11%-80.5M | 5.92%-116.7M | -7.13%-67.02M | 18.87%-124.04M |
Research and development expenses | -14.70%-36.79M | 16.34%-57.7M | -52.98%-32.08M | -46.26%-68.97M | -62.04%-20.97M | -56.45%-47.15M | ---12.94M | ---30.14M | ---- | ---- |
Revaluation surplus | ---- | -153.55%-2.56M | ---- | -55.98%4.78M | ---- | --10.85M | ---- | ---- | ---- | ---- |
-Changes in the fair value of investment property | ---- | -153.55%-2.56M | ---- | -55.98%4.78M | ---- | --10.85M | ---- | ---- | ---- | ---- |
Impairment and provision | ---- | -736.62%-4.5M | ---- | -128.77%-538K | ---- | 1,000.00%1.87M | ---- | -66.99%170K | ---- | --515K |
-Other impairment is provision | ---- | -736.62%-4.5M | ---- | -128.77%-538K | ---- | 1,000.00%1.87M | ---- | -66.99%170K | ---- | --515K |
Special items of operating profit | -23.63%28.78M | 35.98%62.02M | 53.31%37.68M | -27.94%45.61M | 13.02%24.58M | 78.60%63.29M | 32.34%21.75M | 77.95%35.44M | 86.54%16.43M | 132.71%19.91M |
Operating profit | 114.66%26.36M | -7.20%41.77M | -62.27%12.28M | -63.43%45.01M | -30.83%32.55M | 137.38%123.08M | 384.41%47.06M | -15.50%51.85M | -62.44%9.72M | -48.84%61.36M |
Financing cost | -101.03%-8.78M | -64.51%-11.24M | -128.23%-4.37M | -46.08%-6.83M | 34.89%-1.91M | 37.63%-4.68M | 33.03%-2.94M | 48.03%-7.5M | 45.38%-4.39M | 21.88%-14.43M |
Share of profits of associates | -11.97%-683K | -40.88%-1.16M | -1.67%-610K | -0.86%-822K | 33.04%-600K | 62.02%-815K | 50.39%-896K | -230.06%-2.15M | -137.01%-1.81M | 229.82%1.65M |
Earning before tax | 131.37%16.9M | -21.37%29.37M | -75.68%7.31M | -68.23%37.36M | -30.51%30.04M | 178.61%117.58M | 1,127.31%43.23M | -13.12%42.2M | -79.37%3.52M | -51.51%48.58M |
Tax | -555.78%-4.22M | -42.75%-13.73M | 108.90%925K | 64.17%-9.62M | 7.10%-10.39M | -103.87%-26.84M | -737.43%-11.19M | -76.30%-13.16M | 0.82%-1.34M | 52.50%-7.47M |
After-tax profit from continuing operations | 54.15%12.69M | -43.60%15.65M | -58.10%8.23M | -69.43%27.74M | -38.69%19.64M | 212.50%90.75M | 1,365.60%32.04M | -29.36%29.04M | -86.10%2.19M | -51.33%41.11M |
Earning after tax | 54.15%12.69M | -43.60%15.65M | -58.10%8.23M | -69.43%27.74M | -38.69%19.64M | 212.50%90.75M | 1,365.60%32.04M | -29.36%29.04M | -86.10%2.19M | -51.33%41.11M |
Minority profit | 8.76%10.31M | -47.62%9.98M | 16.15%9.48M | 104.51%19.05M | 344.31%8.16M | 471.76%9.31M | 500.22%1.84M | 112.66%1.63M | -214.38%-459K | 188.45%766K |
Profit attributable to shareholders | 290.39%2.38M | -34.81%5.67M | -110.88%-1.25M | -89.32%8.69M | -61.98%11.48M | 197.09%81.43M | 1,041.81%30.2M | -32.06%27.41M | -83.33%2.65M | -52.72%40.35M |
Basic earnings per share | 300.00%0.002 | -34.94%0.0054 | -109.09%-0.001 | -89.28%0.0083 | -62.07%0.011 | 197.69%0.0774 | 866.67%0.029 | -32.11%0.026 | -80.00%0.003 | -52.77%0.0383 |
Diluted earnings per share | 300.00%0.002 | -34.94%0.0054 | -109.09%-0.001 | -89.28%0.0083 | -62.07%0.011 | 197.69%0.0774 | 866.67%0.029 | -32.11%0.026 | -80.00%0.003 | -52.77%0.0383 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data